BRCA1 and ovarian carcinoma: Finally, olaparib is also used for the treatment of adult gynaecological cancer patients with deleterious or suspected deleterious germline BRCA1/2‐mutated (gBRCAm) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy [14].